Effect Of Postdilatation Following Balloon Expandable Transcatheter Aortic Valve Implantation

Below is result for Effect Of Postdilatation Following Balloon Expandable Transcatheter Aortic Valve Implantation in PDF format. You can download or read online all document for free, but please respect copyrighted ebooks. This site does not host PDF files, all document are the property of their respective owners.

Need for a Permanent Pacemaker after Transcatheter Aortic

after Transcatheter Aortic Valve Implantation (TAVI)* Antonis S. Manolis, MD Abstr Act A permanent pacemaker is commonly required in patients undergoing transcatheter aortic valve implantation (TAVI) at ranges up to 30-50%. In general, the incidence is higher with the self- vs balloon-expandable valves. Several risk factors have been iden - tified.

Predictors of Permanent Pacemaker Implantation in Patients

compared with self- expandable and balloon- expandable valves, respectively. CONCLUSIONS: Male sex, baseline atrioventricular conduction delays, intraprocedural atrioventricular block, and use of me- chanically expandable and self-expanding prosthesis served as positive predictors of PPM implantation in patients undergo-

COVER STORY Managing Paravalvular Leaks After TAVR

tion on echocardiography following device implantation.39 The Lotus valve system (Boston Scientific Corporation) consists of a bioprosthetic valve mounted on a self-expand-ing nitinol frame and a catheter-based delivery system for transfemoral delivery and implantation. The valve has a central radiopaque marker to aid positioning and can be

The Effect of Post-Dilatation on Outcomes in the PARTNER 2

OBJECTIVES The purpose of this study was to understand the effects of balloon post-dilatation on outcomes following transcatheter aortic valve replacement with the SAPIEN 3 valve. BACKGROUND Hemodynamics and outcomes with balloon post-dilatation for the SAPIEN 3 valve have not been previously reported.

Impact of Left-Ventricular Dysfunction in Patients With High

intervention, both surgical (SAVR) and transcatheter aortic valve replacement (TAVR) are associated with an important functional and survival benefit, regardless of the LV dysfunction severity.1,4-10 Aortic valve mean gradient may have an incremental value over LVEF to stratify the prognosis of patients undergoing TAVR. The reported mortality in

Incidence and predictors of prosthesis patient mismatch after

Background The balloon-expandable SAPIEN 3 (S3) is superior to the older-generation balloon-expandable SAPIEN XT (XT) in a lower incidence of paravalvular aortic regurgitation, lower complication rates and better survival in transcatheter aortic valve implantation (TAVI). However, prosthesis patient mismatch (PPM) more frequently

3619 Review Article Pacemaker implantation after

Transcatheter aortic valve implantation (TAVI) has been successfully performed in inoperable, high-risk, and intermediate risk patients with low mortality and complication rates (1,2). Trials examining the efficacy and safety of TAVI in low-risk patients are currently enrolling patients. While newer balloon-expandable and self-expanding

Contemporary Application of Cardiovascular Hemodynamics

contemporary transcatheter aortic valve implanta-tion (TAVI). FROM IN VITRO TO IN VIVO HEMODYNAMICS Pulse duplicator and bioreactor models have been used for some time to assess the expected hemo-dynamic function of valvular prostheses.1,2 In vitro assessment of balloon expandable Edwards Sapien transcatheter aortic valves (Edwards Life-

New Gold Standard for the Treatment of Aortic Stenosis

Transcatheter Aortic Valve Implantation Trial) comparing TAVR and SAVR in all comers will be available later this year. Meanwhile, studies assessing the role of TAVR in asymptomatic severe aortic stenosis and moderate aor-tic stenosis with heart failure are underway, potentially expanding the use of TAVR into areas of unmet clinical need.

Postdilatation Of Ballon-expandable Transcatheter Aortic

Background: The Aortic Valve Academic Research Consortium (VARC) endpoint definitions were established to standardize the evaluation of clinical outcomes following transcatheter aortic valve implantation (TAVI). It remains unclear, however, to what extent and in which manner these definitions are used in publications.

Cardiac Death After TAVR

Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187 98. 5. Rodes-Cabau J. Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol 2012;9:15 29. 6. Van Mieghem NM, Chieffo A, Dumonteil N, et al. Trends in outcome after transfemoral transcatheter aortic valve

First author - 小倉記念病院

Percutaneous Edge-to-Edge Mitral Valve Repair. JACC Cardiovasc Interv. 2019 in press. 27.Kawaguchi T, Yamaji K, Ishizu K, Morinaga T, Hayashi M, Isotani A, Kakumoto S, Arai Y, Sakaguchi G, Shirai S, Ando K. Effect of postdilatation following balloon expandable transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2019 in press.

Prior Balloon Valvuloplasty Versus Direct Transcatheter

DIRECTAVI (Direct Transcatheter Aortic Valve Implantation) was a prospective, ran-domized, single-center, open-label trial using the third-generation balloon-expandable Edwards SA-PIEN 3 THV (Edwards Lifesciences, Irvine, California). We hypothesized that TAVR without prior BAV of the aortic valve (test arm; direct implantation group)

Clinical Outcomes of Transcatheter Aortic Valve Implantation

aortic stenosis (AS) deemed to be at intermediate or high risk for surgery.1 4 The transcatheter heart valve (THV) and the relevant procedure have been developed for >20 years.5 However, because of the size limitation of the THV device, certain patients with severe AS have not been able to benefit from TAVR. For example, for the SAPIEN 3 (S3

Publikationen 2019 - Kerckhoff-Klinik

Dahmer M, Hamm C, Hamm K. Multicentre propensity-matched comparison of transcatheter aortic valve implantation using the ACURATE TA/neo self-expanding versus the SAPIEN 3 bal-loon-expandable prosthesis. EuroIntervention. 2019 Nov 20; 15(10): 884-891. 6. Bauer P, Henni S, Dörr O, Bauer T, Hamm CW, Most A. High prevalence of vitamin D insufficien-

The Oversizing Versus Post-Dilatation Trade-Off

impact of calcification and sizing on balloon-expandable versus self-expandable transcatheter heart valves. J Heart Valve Dis 2015;24:10 21. 3. Barbanti M, Petronio AS, Capodanno D, et al. Impact of balloon post-dilation on clinical out-comes after transcatheter aortic valve replace-ment with the self-expanding CoreValve prosthesis.